From 11-13 May, the event united over 200 global researchers and students in neuroinflammation, fostering collaboration and discussing cutting-edge advancements on the historic industrial grounds of Campus Belval. Originally named after its venue on Venusberg Mountain overlooking the city of Bonn, the Venusberg Meeting on Neuroinflammation, led by Prof. Michael Heneka, successfully relocated to the University of Luxembourg.
The conference featured a comprehensive scientific programme covering both basic and clinical aspects of neuroinflammation and neurodegeneration. It explored the many roles of immune mechanisms in neurological diseases and their potential as diagnostic or therapeutic targets but also broadened its scope to new areas.
“This year, we learned a lot of new and interesting things from microbiome research and cancerology. As neuroinflammation is such an interdisciplinary field, it is essential for us to maintain this heterogeneity within the scientific programme,” said Prof. Michael Heneka, Director of the Luxembourg Centre for Systems Biomedicine and host of the event. An exciting addition to this year’s conference was the inclusion of Blitz Talks, which provided a platform for selected young researchers to present their work. “Presenting their unpublished work to an international audience early in their career is an important learning opportunity for young researchers. We were very impressed with the quality of this year’s talks, and it was impossible to pick a single favourite,” Prof. Heneka added.
Throughout the three-day event, over 30 internationally renowned experts took to the stage to present their groundbreaking research and engage in thought-provoking discussions. The conference also offered a vibrant networking environment, with multiple poster-session and a walking dinner where attendees could engage with peers, share ideas and make new connections.
The success of the 7th iteration of the Venusberg Meeting on Neuroinflammation not only solidified its prominent position as a leading event but also firmly established the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg as a key institution in the field of Neuroinflammation.
—
The conference was supported by the Fonds National de la Recherche (FNR) and the following sponsors: Novo Nordisk, AC Immune, Femtonics, Olink, Quanterix, Tcps, Anavex, Mabylon and Novartis.